Related Experiment Videos
Late results of myocardial revascularization
Insights
Myocardial revascularization offers low operative mortality for coronary artery disease patients. This procedure, even with other surgeries, shows excellent long-term survival, suggesting it extends life expectancy.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
- Myocardial revascularization is a key intervention for managing advanced CAD.
- Assessing long-term outcomes and survival rates after revascularization is crucial for patient management.
Purpose of the Study:
- To evaluate the safety and efficacy of myocardial revascularization in a large patient cohort.
- To identify determinants of hospital mortality and long-term survival following the procedure.
- To assess the impact of associated cardiac or noncardiac procedures on outcomes.
Main Methods:
- Retrospective analysis of 1,400 consecutive patients undergoing myocardial revascularization.
- Data collection included patient demographics, surgical procedures, and in-hospital outcomes.
- Long-term follow-up was conducted with a 98% ascertainment rate.
Main Results:
- Hospital mortality was 2.0%, with left ventricular function being a primary determinant.
- Long-term survival was 93.1% at a mean follow-up of three years.
- Left ventricular function also proved to be the prime determinant of overall long-term survival.
Conclusions:
- Myocardial revascularization, alone or combined with other procedures, can be performed with low operative mortality.
- The procedure is associated with excellent long-term survival rates.
- These findings support the hypothesis that myocardial revascularization extends life expectancy in patients with coronary artery disease.
Abstract:
Data are presented on 1,400 consecutive patients who had myocardial revascularization at our institution. The patients ranged in age from 33 to 80 years. Coronary bypass was done with an associated noncardiac procedure in 70 patients and with an associated cardiac procedure in 73 patients. The hospital mortality was 2.0%. Left ventricular function was a primary determinant of hospital mortality. With a 98% follow-up, survival was 93.1% at a mean of three years (range, six months to seven years). Ventricular function was the prime determinant of the overall long-term survival. These data indicate that myocardial revascularization, either alone or with an associated cardiac or noncardiac procedure, can be done with a low operative mortality. Because of the excellent five-year survival in our group of patients followed up for this length of time, we believe these data support the hypothesis that myocardial revascularization extends the life expectancy of patients with coronary artery disease.